Further validation of the cross-talk between GSK3α expression and regulation of the HIF1/VEGFA signaling pathway, both in vivo and in vitro, revealed that GSK3α-mediated cancer tumor angiogenesis was dependent on HIF1α expression in vitro. The gene discussed is GSK3A; the disease is cancer.